Read Full Article
Shares in Actelion Ltd jumped as much as 19 percent to record highs on Friday on reports that U.S. healthcare company Johnson & Johnson was interested in a takeover of the fast-growing Swiss biotechnology firm...
We should then see many other (companies) interested (in Actelion). That will probably include at least one of the two other Basel-based companies.
We continue to believe that management, as quoted on many conference calls and public presentations, remains committed to Actelion as an independent company.